According to the circular dated January 27, 2026, the revised timetable disclosed on January 30, 2026, and the February 11, 2026 announcement reflecting the EGM poll results, all conditions for MicroPort CardioFlow Medtech Corporation’s share consolidation have been fulfilled. The share consolidation became effective on Tuesday, February 24, 2026.

Further details regarding the share consolidation, including trading arrangements, certificate exchange procedures, and odd-lot matching services, are available in the above-mentioned documents. As of the announcement date, the executive directors are Mr. Zhang Ruinian and Mr. Philippe Wanstok; the non-executive directors are Mr. Chen Guoming, Dr. Brian Chang, Mr. Deng Aoyi, and Ms. Wu Xia; and the independent non-executive directors are Mr. Jonathan H. Chou, Ms. Sun Zhixiang, and Dr. Hu Bingshan.